These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 4126124)
1. Clofibrate, nephrotic syndrome, and histological changes in muscle. Denizot M; Fabre J; Pometta D; Wildi E Lancet; 1973 Jun; 1(7815):1326. PubMed ID: 4126124 [No Abstract] [Full Text] [Related]
2. [Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome]. Fabre J; Denizot M; Wildi E; Micheli H; Berthoud S Schweiz Rundsch Med Prax; 1973 Jun; 62(23):732-7. PubMed ID: 4705828 [No Abstract] [Full Text] [Related]
3. Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia. Bridgman JF; Rosen SM; Thorp JM Lancet; 1972 Sep; 2(7776):506-9. PubMed ID: 4115569 [No Abstract] [Full Text] [Related]
4. [Treatment of hyperlipemia with clofibrate in a case of nephrotic syndrome: secondary enzymatic and muscular alterations]. Fabre J; Denizot M; Giromini M; Micheli H J Urol Nephrol (Paris); 1973; 79(4):381-3. PubMed ID: 4720134 [No Abstract] [Full Text] [Related]
5. Clofibrate-induced complications in renal disease: a case report. Pokroy N; Ress S; Gregory MC S Afr Med J; 1977 Nov; 52(20):806-8. PubMed ID: 204061 [TBL] [Abstract][Full Text] [Related]
6. Clofibrate-induced muscular syndrome. Case report with ultrastructural findings and review of the literature. Rimon D; Ludatscher R; Cohen L Isr J Med Sci; 1984 Nov; 20(11):1082-6. PubMed ID: 6511338 [TBL] [Abstract][Full Text] [Related]